Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 110

1.

The duration of macular detachment in retinal detachment is difficult to determine.

Ng H, La Heij EC, van Meurs JC.

Acta Ophthalmol. 2019 Nov 6. doi: 10.1111/aos.14294. [Epub ahead of print] No abstract available.

PMID:
31693277
2.

Retinal oximetry and fractal analysis of capillary maps in sickle cell disease patients and matched healthy volunteers.

Birkhoff WAJ, van Manen L, Dijkstra J, De Kam ML, van Meurs JC, Cohen AF.

Graefes Arch Clin Exp Ophthalmol. 2019 Sep 16. doi: 10.1007/s00417-019-04458-0. [Epub ahead of print]

PMID:
31529320
3.

The Influence of Prolongation of Interruptions of Preoperative Posturing and Other Clinical Factors on the Progress of Macula-On Retinal Detachment.

de Jong JH, Vigueras-Guillén JP, Wubbels RJ, Timman R, Vermeer KA, van Meurs JC.

Ophthalmol Retina. 2019 Nov;3(11):938-946. doi: 10.1016/j.oret.2019.05.004. Epub 2019 May 13.

PMID:
31253473
4.

STRICT POSTURING WITH OR WITHOUT BILATERAL PATCHING FOR POSTERIOR VITREOUS DETACHMENT-RELATED VITREOUS HEMORRHAGE.

van Etten PG, van Overdam KA, Reyniers R, Veckeneer M, Faridpooya K, Wubbels RJ, Manning S, La Heij EC, van Meurs JC.

Retina. 2019 May 23. doi: 10.1097/IAE.0000000000002561. [Epub ahead of print]

PMID:
31136460
5.

The Effect of Compliance With Preoperative Posturing Advice and Head Movements on the Progression of Macula-On Retinal Detachment.

de Jong JH, de Koning K, den Ouden T, van Meurs JC, Vermeer KA.

Transl Vis Sci Technol. 2019 Mar 26;8(2):4. doi: 10.1167/tvst.8.2.4. eCollection 2019 Mar.

6.

PROPHYLACTIC LASER TREATMENT TO DECREASE THE INCIDENCE OF RETINAL DETACHMENT IN FELLOW EYES OF IDIOPATHIC GIANT RETINAL TEARS.

Verhoekx JSN, van Etten PG, Wubbels RJ, van Meurs JC, van Overdam KA.

Retina. 2019 Mar 6. doi: 10.1097/IAE.0000000000002494. [Epub ahead of print]

PMID:
30865062
7.

Vitreous Wiping, a new technique for removal of vitreous cortex remnants during vitrectomy.

van Overdam KA, van Etten PG, van Meurs JC, Manning SS.

Acta Ophthalmol. 2019 Aug;97(5):e747-e752. doi: 10.1111/aos.13991. Epub 2018 Dec 7.

8.

Towards Better Safety Standards for Vitreoretinal Medical Devices.

Van Meurs JC, Wolf S.

Ophthalmologica. 2018;240(4):235. doi: 10.1159/000493561. Epub 2018 Oct 25. No abstract available.

9.

Another perspective on the treatment of postoperative endophthalmitis: Unclear evidence for the role of vitrectomy.

van Meurs JC, van Dissel JTJ.

Acta Ophthalmol. 2018 Dec;96(8):e1042-e1043. doi: 10.1111/aos.13810. Epub 2018 Jun 4. No abstract available.

PMID:
29862645
10.

Visual acuity of 20/32, 13.5 years after a retinal pigment epithelium and choroid graft transplantation.

van Zeeburg EJT, Maaijwee KJM, van Meurs JC.

Am J Ophthalmol Case Rep. 2018 Feb 1;10:62-64. doi: 10.1016/j.ajoc.2018.01.042. eCollection 2018 Jun.

11.

Thrombin Generation in Vitreous and Subretinal Fluid of Patients with Retinal Detachment.

Mulder VC, Bastiaans J, van Leuven CJM, van Meurs JC, Kluft C.

Ophthalmologica. 2018;240(1):23-28. doi: 10.1159/000487757. Epub 2018 Apr 4.

12.

Numerical study of the effect of head and eye movement on progression of retinal detachment.

Vroon J, de Jong JH, Aboulatta A, Eliasy A, van der Helm FCT, van Meurs JC, Wong D, Elsheikh A.

Biomech Model Mechanobiol. 2018 Aug;17(4):975-983. doi: 10.1007/s10237-018-1006-y. Epub 2018 Feb 24.

PMID:
29478194
13.

A prospective multicentre randomized placebo-controlled superiority trial in patients with suspected bacterial endophthalmitis after cataract surgery on the adjuvant use of intravitreal dexamethasone to intravitreal antibiotics.

Manning S, Ugahary LC, Lindstedt EW, Wubbels RJ, van Dissel JT, Jansen JTG, Gan I, van Goor AT, Bennebroek CA, van der Werf DJ, Ossewaarde-van Norel A, Mayland Nielsen CC, Tilanus M, van den Biesen PR, Schellekens PA, La Heij E, Faridpooya K, van Overdam K, Veckeneer M, van Meurs JC.

Acta Ophthalmol. 2018 Jun;96(4):348-355. doi: 10.1111/aos.13610. Epub 2017 Dec 7.

14.

Dabigatran inhibits intravitreal thrombin activity.

Bastiaans J, Mulder VC, van Meurs JC, Smits-Te Nijenhuis M, van Holten-Neelen C, van Hagen PM, Dik WA.

Acta Ophthalmol. 2018 Aug;96(5):452-458. doi: 10.1111/aos.13630. Epub 2017 Nov 30.

15.

More breakdown of blood ocular barriers after vitrectomy than scleral buckling.

Mulder VC, La Heij EC, van Meurs JC.

Acta Ophthalmol. 2018 Nov;96(7):e894-e895. doi: 10.1111/aos.13605. Epub 2017 Nov 2. No abstract available.

16.

Postoperative aqueous humour flare as a surrogate marker for proliferative vitreoretinopathy development.

Mulder VC, van Dijk EHC, van Meurs IA, La Heij EC, van Meurs JC.

Acta Ophthalmol. 2018 Mar;96(2):192-196. doi: 10.1111/aos.13560. Epub 2017 Oct 25.

17.

Preoperative Posturing of Patients with Macula-On Retinal Detachment Reduces Progression Toward the Fovea.

de Jong JH, Vigueras-Guillén JP, Simon TC, Timman R, Peto T, Vermeer KA, van Meurs JC.

Ophthalmology. 2017 Oct;124(10):1510-1522. doi: 10.1016/j.ophtha.2017.04.004. Epub 2017 May 9.

18.

Higher vitreous concentrations of dabigatran after repeated oral administration.

Mulder VC, Kluft C, van Etten PG, La Heij EC, van Meurs JC.

Acta Ophthalmol. 2017 Jun;95(4):e345-e346. doi: 10.1111/aos.13348. Epub 2017 Jan 27. No abstract available.

19.

Preoperative aqueous humour flare values do not predict proliferative vitreoretinopathy in patients with rhegmatogenous retinal detachment.

Mulder VC, Tode J, van Dijk EH, Purtskhvanidze K, Roider J, van Meurs JC, Treumer F.

Br J Ophthalmol. 2017 Sep;101(9):1285-1289. doi: 10.1136/bjophthalmol-2016-309134. Epub 2017 Jan 11.

PMID:
28077370
20.

Vitreous and subretinal fluid concentrations of orally administered dabigatran in patients with rhegmatogenous retinal detachment.

Mulder VC, Kluft C, van Meurs JC.

Acta Ophthalmol. 2016 Nov;94(7):663-667. doi: 10.1111/aos.13186. Epub 2016 Aug 6.

21.

What made you wait so long? Delays in presentation of retinal detachment: knowledge is related to an attached macula.

Eijk ES, Busschbach JJ, Timman R, Monteban HC, Vissers JM, van Meurs JC.

Acta Ophthalmol. 2016 Aug;94(5):434-40. doi: 10.1111/aos.13016. Epub 2016 Mar 24.

22.

INTRAVITREAL VERSUS SUBRETINAL ADMINISTRATION OF RECOMBINANT TISSUE PLASMINOGEN ACTIVATOR COMBINED WITH GAS FOR ACUTE SUBMACULAR HEMORRHAGES DUE TO AGE-RELATED MACULAR DEGENERATION: An Exploratory Prospective Study.

de Jong JH, van Zeeburg EJ, Cereda MG, van Velthoven ME, Faridpooya K, Vermeer KA, van Meurs JC.

Retina. 2016 May;36(5):914-25. doi: 10.1097/IAE.0000000000000954.

PMID:
26807631
23.

Intentional continuous shallowing of the anterior chamber, a procedure to prevent lens touch during phakic vitrectomy.

Mulder V, Veckeneer M, van Rooij J, Delaey C, van Meurs JC.

Acta Ophthalmol. 2016 Mar;94(2):e163-4. doi: 10.1111/aos.12804. Epub 2015 Aug 13. No abstract available.

24.

BAX and BCL-2 polymorphisms, as predictors of proliferative vitreoretinopathy development in patients suffering retinal detachment: the Retina 4 project.

Pastor-Idoate S, Rodríguez-Hernández I, Rojas J, Fernández I, García-Gutierrez MT, Ruiz-Moreno JM, Rocha-Sousa A, Ramkissoon YD, Harsum S, MacLaren RE, Charteris DG, Van Meurs JC, González-Sarmiento R, Pastor JC; Genetics on PVR Study Group.

Acta Ophthalmol. 2015 Nov;93(7):e541-9. doi: 10.1111/aos.12718. Epub 2015 May 19.

25.

Prospective, Randomized Intervention Study Comparing Retinal Pigment Epithelium-Choroid Graft Surgery and Anti-VEGF Therapy in Patients with Exudative Age-Related Macular Degeneration.

van Zeeburg EJ, Cereda MG, Amarakoon S, van Meurs JC.

Ophthalmologica. 2015;233(3-4):134-45. doi: 10.1159/000380829. Epub 2015 Mar 26.

PMID:
25832909
26.

Chloroquine and Hydroxychloroquine Increase Retinal Pigment Epithelial Layer Permeability.

Korthagen NM, Bastiaans J, van Meurs JC, van Bilsen K, van Hagen PM, Dik WA.

J Biochem Mol Toxicol. 2015 Jul;29(7):299-304. doi: 10.1002/jbt.21696. Epub 2015 Mar 9.

PMID:
25752684
27.

Increased intraocular pressure after vitreoretinal surgery as a cause of ipsilateral amaurosis fugax upon rising to a standing position.

Spielberg LH, van Meurs JC.

Acta Ophthalmol. 2015 Feb;93(1):e90. doi: 10.1111/aos.12580. No abstract available.

28.

Direct Blood Flow Measurements in a Free RPE-Choroid Graft with Phase-Resolved Doppler OCT.

van Zeeburg EJ, Braaf B, Cereda MG, van Meurs JC, de Boer JF.

Transl Vis Sci Technol. 2015 Jan 13;4(1):2. eCollection 2015 Jan.

29.

[Laser pointers are not toys; eye injury with permanent loss of visual acuity].

Keunen JE, Delbecq AL, Cruysberg JR, van Meurs JC, Gan IM, Berendschot TT.

Ned Tijdschr Geneeskd. 2014;158:A7813. Review. Dutch.

PMID:
25308223
30.

A prospective multicenter randomized placebo-controlled trial of dexamethasone as an adjuvant in the treatment of postoperative bacterial endophthalmitis: interim safety analysis of the study drug and analysis of overall treatment results.

Lindstedt EW, Bennebroek CA, van der Werf DJ, Veckeneer M, Norel AO, Nielsen CC, Wubbels RJ, van Dissel JT, van Meurs JC.

Graefes Arch Clin Exp Ophthalmol. 2014 Oct;252(10):1631-7. doi: 10.1007/s00417-014-2770-8. Epub 2014 Aug 10.

PMID:
25107542
31.

Predicting proliferative vitreoretinopathy: temporal and external validation of models based on genetic and clinical variables.

Rojas J, Fernandez I, Pastor JC, MacLaren RE, Ramkissoon Y, Harsum S, Charteris DG, Van Meurs JC, Amarakoon S, Garcia-Arumi J, Ruiz-Moreno JM, Rocha-Sousa A, Brion M, Carracedo A; Genetics on PVR Study Group (web file).

Br J Ophthalmol. 2015 Jan;99(1):41-8. doi: 10.1136/bjophthalmol-2014-305263. Epub 2014 Jul 29.

PMID:
25075124
32.

The role of thrombin in proliferative vitreoretinopathy.

Bastiaans J, van Meurs JC, Mulder VC, Nagtzaam NM, Smits-te Nijenhuis M, Dufour-van den Goorbergh DC, van Hagen PM, Hooijkaas H, Dik WA.

Invest Ophthalmol Vis Sci. 2014 Jul 11;55(7):4659-66. doi: 10.1167/iovs.14-14818.

PMID:
25015355
33.

Deferred laser photocoagulation of relaxing retinotomies under silicone oil tamponade to reduce recurrent macular detachment in severe proliferative vitreoretinopathy.

Veckeneer M, Maaijwee K, Charteris DG, van Meurs JC.

Graefes Arch Clin Exp Ophthalmol. 2014 Oct;252(10):1539-44. doi: 10.1007/s00417-014-2605-7. Epub 2014 Mar 18.

PMID:
24638256
34.

Developing cellular therapies for retinal degenerative diseases.

Bharti K, Rao M, Hull SC, Stroncek D, Brooks BP, Feigal E, van Meurs JC, Huang CA, Miller SS.

Invest Ophthalmol Vis Sci. 2014 Feb 26;55(2):1191-202. doi: 10.1167/iovs.13-13481.

35.

Thrombin induces epithelial-mesenchymal transition and collagen production by retinal pigment epithelial cells via autocrine PDGF-receptor signaling.

Bastiaans J, van Meurs JC, van Holten-Neelen C, Nagtzaam NM, van Hagen PM, Chambers RC, Hooijkaas H, Dik WA.

Invest Ophthalmol Vis Sci. 2013 Dec 19;54(13):8306-14. doi: 10.1167/iovs.13-12383.

PMID:
24302586
36.
37.

Factor Xa and thrombin stimulate proinflammatory and profibrotic mediator production by retinal pigment epithelial cells: a role in vitreoretinal disorders?

Bastiaans J, van Meurs JC, van Holten-Neelen C, Nijenhuis MS, Kolijn-Couwenberg MJ, van Hagen PM, Kuijpers RW, Hooijkaas H, Dik WA.

Graefes Arch Clin Exp Ophthalmol. 2013 Jul;251(7):1723-33. doi: 10.1007/s00417-013-2335-2. Epub 2013 Apr 20.

PMID:
23604512
38.

A genetic case-control study confirms the implication of SMAD7 and TNF locus in the development of proliferative vitreoretinopathy.

Rojas J, Fernandez I, Pastor JC, Maclaren RE, Ramkissoon Y, Harsum S, Charteris DG, Van Meurs JC, Amarakoon S, Ruiz-Moreno JM, Rocha-Sousa A, Brion M, Carracedo A; Genetics on PVR Study Group.

Invest Ophthalmol Vis Sci. 2013 Mar 5;54(3):1665-78. doi: 10.1167/iovs.12-10931.

PMID:
23258148
39.

Literature review of recombinant tissue plasminogen activator used for recent-onset submacular hemorrhage displacement in age-related macular degeneration.

van Zeeburg EJ, van Meurs JC.

Ophthalmologica. 2013;229(1):1-14. doi: 10.1159/000343066. Epub 2012 Oct 12. Review.

40.

Recombinant tissue plasminogen activator, vitrectomy, and gas for recent submacular hemorrhage displacement due to retinal macroaneurysm.

van Zeeburg EJ, Cereda MG, van Meurs JC.

Graefes Arch Clin Exp Ophthalmol. 2013 Mar;251(3):733-40. doi: 10.1007/s00417-012-2116-3. Epub 2012 Aug 4.

PMID:
22865261
41.

Suspected bacterial endophthalmitis following intravitreal anti-VEGF injection: case series and literature review.

Hoevenaars NE, Gans D, Missotten T, van Rooij J, Lesaffre E, van Meurs JC.

Ophthalmologica. 2012;228(3):143-7. Epub 2012 Jul 12. Review.

42.

Single-sided and small-scaled grasping of delicate tissues: effectiveness of indirect heat-induced attachment and detachment.

Tukker AA, Knulst AJ, Maaijwee KJ, Schutte S, Van Zeeburg EJ, Van Meurs JC, Dankelman J.

Minim Invasive Ther Allied Technol. 2012 Nov;21(6):388-95. doi: 10.3109/13645706.2011.644854. Epub 2011 Dec 27.

PMID:
22200106
43.

Phase-stabilized optical frequency domain imaging at 1-µm for the measurement of blood flow in the human choroid.

Braaf B, Vermeer KA, Sicam VA, van Zeeburg E, van Meurs JC, de Boer JF.

Opt Express. 2011 Oct 10;19(21):20886-903. doi: 10.1364/OE.19.020886.

PMID:
21997098
44.

Six months treatment with ibopamine in patients with hypotony after vitreoretinal surgery for retinal detachment, uveitis or penetrating trauma.

Ganteris-Gerritsen E, Ugahary LC, Jansen J, Mulder PG, Cohen AF, van Meurs JC.

Retina. 2012 Apr;32(4):742-7. doi: 10.1097/IAE.0b013e3182265177.

PMID:
21909052
45.

A free retinal pigment epithelium-choroid graft in patients with exudative age-related macular degeneration: results up to 7 years.

van Zeeburg EJ, Maaijwee KJ, Missotten TO, Heimann H, van Meurs JC.

Am J Ophthalmol. 2012 Jan;153(1):120-7.e2. doi: 10.1016/j.ajo.2011.06.007. Epub 2011 Sep 9.

PMID:
21907969
46.

The concentration of povidone-iodine for preoperative disinfection: relation to endophthalmitis incidence.

van Rooij J, Boks AL, Sprenger A, Ossewaarde JM, van Meurs JC.

Am J Ophthalmol. 2011 Aug;152(2):321; author reply 321-2. doi: 10.1016/j.ajo.2011.03.036. No abstract available.

PMID:
21784195
47.

Early perfusion of a free RPE-choroid graft in patients with exudative macular degeneration can be imaged with spectral domain-OCT.

van Zeeburg EJ, Cereda MG, van der Schoot J, Pertile G, van Meurs JC.

Invest Ophthalmol Vis Sci. 2011 Jul 29;52(8):5881-6. doi: 10.1167/iovs.11-7245.

PMID:
21693613
48.

The neonatal Fc receptor is expressed by human retinal pigment epithelial cells and is downregulated by tumour necrosis factor-alpha.

van Bilsen K, van Hagen PM, Bastiaans J, van Meurs JC, Missotten T, Kuijpers RW, Hooijkaas H, Dingjan GM, Baarsma GS, Dik WA.

Br J Ophthalmol. 2011 Jun;95(6):864-8. doi: 10.1136/bjo.2010.187930. Epub 2011 Jan 7.

PMID:
21216798
49.

The effect of a preoperative subconjuntival injection of dexamethasone on blood-retinal barrier breakdown following scleral buckling retinal detachment surgery: a prospective randomized placebo-controlled double blind clinical trial.

Bali E, Feron EJ, Peperkamp E, Veckeneer M, Mulder PG, van Meurs JC.

Graefes Arch Clin Exp Ophthalmol. 2010 Jul;248(7):957-62. doi: 10.1007/s00417-010-1319-8. Epub 2010 Feb 25.

50.

Cost-effectiveness of autologous retinal pigment epithelium and choroid translocation in neovascular AMD.

Neubauer AS, Liakopoulos S, van Meurs JC, Kirchhof B.

Int J Ophthalmol. 2010;3(3):228-33. doi: 10.3980/j.issn.2222-3959.2010.03.11. Epub 2010 Sep 18.

Supplemental Content

Loading ...
Support Center